Crescent Capital holder plans $5.1M share sale

A 10% stockholder of Crescent Capital BDC, Inc. has filed to sell 525,000 CCAP shares under Rule 144, valued at about $5.1 million.

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. (CCAP) has a notice of proposed sale under Rule 144 filed on behalf of Fidelity & Guaranty Life Insurance, identified as a 10% stockholder. The filing covers a proposed sale of 525,000 shares of common stock through Keefe, Bruyette & Woods on NASDAQ on or after August 24, 2026, with an aggregate market value of $5,118,750.

The notice states that Crescent Capital BDC, Inc. has 36,845,952 shares outstanding, and that the selling stockholder originally acquired 4,205,307 shares of common stock in the issuer’s November 16, 2021 initial public offering for cash.

Key Figures

Shares proposed to be sold under Rule 144: 525,000 shares Aggregate market value of proposed sale: $5,118,750 Shares outstanding: 36,845,952 shares +2 more

5 metrics

Shares proposed to be sold under Rule 144 525,000 shares Common stock proposed for sale by Fidelity & Guaranty Life Insurance

Aggregate market value of proposed sale $5,118,750 Market value of 525,000 Crescent Capital BDC, Inc. shares

Shares outstanding 36,845,952 shares Crescent Capital BDC, Inc. common shares outstanding

Shares originally acquired in IPO 4,205,307 shares Common shares acquired November 16, 2021 IPO for cash

Planned sale date August 24, 2026 Intended date for Rule 144 sale on NASDAQ

Key Terms

Rule 144, 10% Stockholder, initial public offering (IPO), aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10% Stockholder financial

"In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. 10% Stockholder"

initial public offering (IPO) financial

"Common | 11/16/2021 | IPO | ISSUER | | | 4205307 | 11/16/2021 | CASH"

An initial public offering (IPO) is the process by which a private company sells its shares to the public for the first time, allowing anyone to buy a piece of the company. It matters to investors because it provides an opportunity to invest early in a company's growth, potentially earning profits if the company becomes successful. Essentially, an IPO turns a private business into a publicly traded one, opening it up to a wider pool of investors.

aggregate market value financial

"Crescent Capital BDC Inc | KEEFE BRUYETTE AND WOODS INC ... | 525000 | 5118750.00 | 36845952"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing disclose for Crescent Capital BDC, Inc. (CCAP)?

The notice discloses that Fidelity & Guaranty Life Insurance, a 10% stockholder, plans to sell 525,000 CCAP common shares under Rule 144 through Keefe, Bruyette & Woods on NASDAQ, with an aggregate market value of $5,118,750.

How many Crescent Capital BDC (CCAP) shares are proposed to be sold under this Form 144?

The filing covers a proposed sale of 525,000 shares of Crescent Capital BDC, Inc. common stock. These shares are to be sold under Rule 144 through Keefe, Bruyette & Woods on NASDAQ, with the intended sale date listed as August 24, 2026.

What is the total market value of the CCAP shares covered by this Form 144?

The Form 144 states an aggregate market value of $5,118,750 for the 525,000 Crescent Capital BDC, Inc. common shares proposed for sale by Fidelity & Guaranty Life Insurance.

How many Crescent Capital BDC (CCAP) shares are outstanding according to this filing?

The notice reports that Crescent Capital BDC, Inc. has 36,845,952 shares outstanding. This figure provides context for the size of the 525,000-share proposed Rule 144 sale.

When and how did the selling stockholder acquire its CCAP shares?

The filing states that the selling stockholder acquired 4,205,307 CCAP common shares in the issuer’s November 16, 2021 initial public offering (IPO), with the form indicating the acquisition was for cash.

Who is the selling security holder in the Crescent Capital BDC (CCAP) Form 144?

The selling security holder is Fidelity & Guaranty Life Insurance, identified in the Form 144 as a 10% stockholder of Crescent Capital BDC, Inc., for whose account the securities are to be sold under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 01:08 PM Accepted by SEC EDGAR 09/04/2026 - 01:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000854241
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crescent Capital BDC, Inc.
SEC File Number	814-01132
Address of Issuer	11100 Santa Monica Blvd Los Angeles CALIFORNIA 90025
Phone	(310) 235-5900
Name of Person for Whose Account the Securities are To Be Sold	FIDELITY & GUARANTY LIFE INSURANCE CO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Crescent Capital BDC Inc	KEEFE BRUYETTE AND WOODS INC 787 7TH AVE NEW YORK NY 10019	525000	5118750.00	36845952	08/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/16/2021	IPO	ISSUER			4205307	11/16/2021	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tessa Cantonwine
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)